Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Imaging lung tumor metastasis with (89)Zr-DFO-crizanlizumab targeting P-selectin
    Meeting Abstract

    Majekodunmi, O.; Pratt, E.; Kaminsky, S.; Raashed, R.; Heller, D.; Laplant, Q.; Lewis, J.
    Nuclear Medicine and Biology (2023)

    Fulltext@MSK | Save
  • Targeting brain tumours with radiolabelled chlorotoxin, a scorpion venom peptide
    Meeting Abstract

    Zafar, I.; Li, K.; Zammit, J.; Palm, K. P.; Davydova, M.; Varshney, M.; Lu, L.; Tran, T.; Bergstrom, T.; Swartling, F. J.; more...
    Nuclear Medicine and Biology (2023)

    Fulltext@MSK | Save
  • Cerenkov luminescence signal enhancement using hyperbolic metamaterials as a multi-modal imaging probe
    Meeting Abstract

    Boykoff, N.; Grimm, J.; O'Brien, S.
    Nuclear Medicine and Biology (2023)

    Fulltext@MSK | Save
  • A dysfunctional program imprinted by Prostaglandin E2 signaling shuts off NK cell communication pathways and disables immunosurveillance of metastasis
    Meeting Abstract

    Pedde, A.; Baumann, T.; Kim, H.; Donakonda, S.; Bayerl, F.; Meiser, P.; Hirschberger, A.; Klement, C.; Grassmann, S.; Òˆllinger, R.; more...
    European Journal of Immunology (2023)

    Fulltext@MSK | Save
  • Targeting altered glycosylation for broad cancer detection
    Meeting Abstract

    Kudelka, M. R.; Gu, W.; Matsumoto, Y.; Ju, T.; Barnes, R. H. 2nd; Kardish, R. J.; Heimburg-Molinaro, J.; Lehoux, S.; Zeng, J.; Cohen, C.; more...
    Glycobiology (2023)

    Fulltext@MSK | Save
  • Treatment outcomes and prognostic factors with lenalidomide, bortezomib, and dexamethasone (RVd) alone versus RVd plus autologous stem cell transplantation (ASCT) in African American (AA) patients (pts) with newly diagnosed multiple myeloma (NDMM) in the DETERMINATION phase 3 trial
    Meeting Abstract

    Houde, C. A.; Khan, A.; Jacobus, S. J.; Hassoun, H.; Anderson, L. D. Jr; Merz, L. E.; Zon, R. L.; Efebera, Y.; Buck, T.; Innis-Shelton, R. D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Establishing costs for commercial chimeric antigen receptor T-cell (tisagenlecleucel; kymriah) in children and young adult B-cell acute lymphoblastic leukemia; A merged analysis from the PRWCC and PHIS
    Meeting Abstract

    Satwani, P.; Chao, K.; Lopez-Garcia, M.; Hall, M.; Jin, Z.; Winestone, L. E.; Friedman, D. N.; Phelan, R.; Baggott, C.; John, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Practice patterns of transplant centers regarding maintenance treatment post allogeneic hematopoietic cell transplantation in acute myeloid leukemia: A survey on behalf of the EBMT Acute Leukemia Working Party
    Meeting Abstract

    Abou Dalle, I.; Labopin, M.; Khvedelidze, I.; Baron, F.; Brissot, E.; Bug, G.; Esteve, J.; Giebel, S.; Gorin, N. C.; Lanza, F.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Assessment of outcomes of consolidation therapy by number of cycles of blinatumomab received in newly diagnosed measurable residual disease negative patients with B-lineage acute lymphoblastic leukemia: In the ECOG-ACRIN E1910 Randomized Phase III National Clinical Trials Network Trial
    Meeting Abstract

    Luger, S. M.; Sun, Z.; Mattison, R. J.; Paietta, E.; Roberts, K. G.; Zhang, Y.; Racevckis, J.; Lazarus, H. M.; Rowe, J. M.; Arber, D. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with accelerated/blast-phase MPNs that received allogeneic stem-cell transplant in the current era of myeloid therapies
    Meeting Abstract

    Patel, A. A.; Yoon, J. J.; Johnston, H.; Davidson, M. B.; Viswabandya, A.; Shallis, R. M.; Chen, E. C.; Burkart, M.; Oh, T. S.; Iyer, S. G.; more...
    Blood (2023)

    Fulltext@MSK | Save